Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | BNT151 |
Synonyms | |
Therapy Description |
BNT151 comprises a formulation of messenger RNA encoding modified IL-2, which may lead to activation of antitumor immune response (NCI Drug Dictionary). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
BNT151 | BNT 151|BN-T151 | BNT151 comprises a formulation of messenger RNA encoding modified IL-2, which may lead to activation of antitumor immune response (NCI Drug Dictionary). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT04455620 | Phase Ib/II | BNT151 | BNT151 as a Monotherapy and in Combination With Other Anti-cancer Agents in Patients With Solid Tumors | Active, not recruiting | USA | ESP | 0 |